These processes will lead to increased sensitivity of cancer cells to combination treatment with chemotherapy, such as carboplatin, paclitaxel and cisplatin, and will help to prevent CD8+ T cell exhaustion to impede tumor growth and metastasis. This evidence concerns the gene CD8A and cancer.